📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma. (2019)

First Author: Nakamura M

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/2162402x.2019.1593811

PubMed Identifier: 31069161

Publication URI: http://europepmc.org/abstract/MED/31069161

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncoimmunology

Issue: 6

ISSN: 2162-4011